Clinical Trials Directory

Trials / Unknown

UnknownNCT05589636

Effect of Bergamot Juice on LDL Cholesterol Level in Healthy Subjects

A Randomized Controlled Intervention Study to Assess the Effect of Bergamot Juice on LDL Cholesterol Level in Healthy Subjects

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
44 (estimated)
Sponsor
Azienda Ospedaliero-Universitaria di Parma · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

A single-centre, randomized (1:1), open label, controlled study to assess the lipid-lowering effect at 12 weeks of 400 cc/die bergamot juice consumption compared to free diet in healthy subjects

Detailed description

Cardiovascular diseases (CV) are the first cause of morbidity and mortality in industrialized countries. Hypercholesterolemia is the main CV risk factor: high cholesterol values are directly and linearly correlated with CV events and mortality in the absence of a threshold value. Intervention studies show unequivocally how the decrease in cholesterol levels significantly reduces CV risk. Bergamot juice is considered a possible food with nutraceutical activity, especially as regards the control of blood cholesterol levels. It is now known that bergamot juice has chemical components that can positively affect blood cholesterol levels. These compounds are called 3-hydroxy-3-methyl flavonoids (HMG-flavonoids) and are peculiar to some citrus plants and in particular to the Citrus bergamia species. The aim of this study is to provide clinical evidence of the effect of these metabolites on cholesterol levels. Specifically, a single-centre, randomized (1:1), open label, controlled study is conducted in healthy subjects to evaluate the possible lipid-lowering effects at 12 weeks of 400 cc/die of bergamot juice consumption compared to a free diet. Changes in the following parameters: body mass index (BMI kg/m²), waist circumference, glycemia, insulin, glycated hemoglobin (HbA1C), total cholesterol, HDL cholesterol and triglycerides, plasma levels of inflammatory cytokines, C-reactive protein (hsCRP) and Proprotein convertase subtilisin / kexin type 9 (PCSK9) are also investigated at 12 weeks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBergamot JuiceBergamot Juice (35% in water)

Timeline

Start date
2022-02-10
Primary completion
2022-12-01
Completion
2023-07-01
First posted
2022-10-21
Last updated
2022-10-21

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05589636. Inclusion in this directory is not an endorsement.